Clinical Trials Directory

Trials / Completed

CompletedNCT03178708

Amantadine Sulphate Usage in Spine Deformities Corrective Surgeries Patients

The Implications of Amantadine Sulphate Usage in Spine Deformities Corrective Surgeries Patients as Regard Its Effect on the Duration of Wake up Test and Postoperative Opioid Consumption

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

During the surgical procedure of scoliosis correction, large surgery extent and long-lasting strong nociceptive stimulation lead to postoperative pain formation of greater intensity compared with other orthopedic interventions. In these patients, duration of postoperative symptoms is longer, and may lead to persistent pain formation due to developing neuroplastic changes in the central nervous system.

Detailed description

Instrumentation in correction operations for spinal deformities as vertebral fusion, congenital and traumatic scoliosis, carries a 0.5-5% risk of injuring the spinal cord during spinal surgery. These complications are generally results of complex factors such as direct effects of compression on the spinal cord, distraction, the effects of spinal ischemia or arterial hypotension. The purpose of the wake-up test is to monitor voluntary motor function of the lower limbs once the vertebrae have been instrumented and distracted. The depth of anesthesia is gradually lightened up to the point where patients are able to respond to verbal commands. As the voluntary movement of lower extremities is demonstrated, the depth of anesthesia is increased to complete the surgery.

Conditions

Interventions

TypeNameDescription
DRUGGroup A amantadine sulfateinfusion solution for slowly intravenous application 3 hours preoperative
OTHERGroup B ringer lactateinfusion solution for intravenous application 3 hours preoperative

Timeline

Start date
2017-08-01
Primary completion
2019-12-30
Completion
2019-12-30
First posted
2017-06-07
Last updated
2021-01-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03178708. Inclusion in this directory is not an endorsement.